Puma Interest Income vs Gross Profit Analysis
PBYI Stock | USD 5.14 0.33 6.86% |
Puma Biotechnology financial indicator trend analysis is much more than just breaking down Puma Biotechnology prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Puma Biotechnology is a good investment. Please check the relationship between Puma Biotechnology Interest Income and its Gross Profit accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.
Interest Income vs Gross Profit
Interest Income vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Puma Biotechnology Interest Income account and Gross Profit. At this time, the significance of the direction appears to have weak relationship.
The correlation between Puma Biotechnology's Interest Income and Gross Profit is 0.39. Overlapping area represents the amount of variation of Interest Income that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Puma Biotechnology, assuming nothing else is changed. The correlation between historical values of Puma Biotechnology's Interest Income and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Income of Puma Biotechnology are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Interest Income i.e., Puma Biotechnology's Interest Income and Gross Profit go up and down completely randomly.
Correlation Coefficient | 0.39 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Puma Biotechnology minus its cost of goods sold. It is profit before Puma Biotechnology operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most indicators from Puma Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Puma Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.As of now, Puma Biotechnology's Issuance Of Capital Stock is increasing as compared to previous years. The Puma Biotechnology's current Enterprise Value Over EBITDA is estimated to increase to 5.42, while Selling General Administrative is projected to decrease to under 65.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 10.6M | 8.9M | 10.2M | 9.1M | Interest Income | 160K | 813K | 2.4M | 1.5M |
Puma Biotechnology fundamental ratios Correlations
Click cells to compare fundamentals
Puma Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Puma Biotechnology fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 234.9M | 244.2M | 226.6M | 222.1M | 230.5M | 165.1M | |
Total Stockholder Equity | 17.5M | (6M) | (2.4M) | 21.6M | 53.4M | 63.0M | |
Net Debt | 60.2M | 35.7M | 53.5M | 38.1M | 26.9M | 28.3M | |
Cash | 60M | 85.3M | 63.1M | 76.2M | 84.6M | 68.5M | |
Cash And Short Term Investments | 60M | 85.3M | 63.1M | 76.2M | 95.9M | 71.9M | |
Common Stock Shares Outstanding | 38.8M | 39.6M | 40.6M | 44.9M | 47.6M | 32.7M | |
Liabilities And Stockholders Equity | 234.9M | 244.2M | 226.6M | 222.1M | 230.5M | 165.1M | |
Other Stockholder Equity | 1.3B | 1.3B | 1.4B | 1.4B | 1.4B | 762.9M | |
Total Liab | 217.4M | 250.2M | 229.0M | 200.5M | 177.1M | 108.6M | |
Total Current Assets | 166.3M | 146.1M | 140.0M | 134.3M | 156.2M | 127.0M | |
Total Current Liabilities | 90.8M | 114.3M | 109.6M | 77.5M | 99.4M | 56.7M | |
Retained Earnings | (1.3B) | (1.3B) | (1.4B) | (1.4B) | (1.3B) | (1.3B) | |
Accounts Payable | 19.2M | 12.1M | 11.2M | 6.4M | 6.9M | 12.3M | |
Other Current Liab | 69.0M | 2.5M | 2.3M | 66.9M | 53.7M | 30.7M | |
Other Liab | 9M | 32.3M | 6.4M | 12.8M | 14.7M | 7.6M | |
Net Tangible Assets | (23.0M) | (80.1M) | (68.6M) | 21.6M | 19.4M | 18.5M | |
Property Plant And Equipment Net | 21.8M | 18.9M | 15.8M | 12.5M | 8.6M | 8.4M | |
Non Current Assets Total | 68.6M | 98.1M | 86.6M | 87.8M | 74.3M | 49.8M | |
Non Currrent Assets Other | 6.3M | 5.1M | 4.7M | 4.7M | 2.7M | 5.0M | |
Other Assets | 6.3M | 5.1M | 4.7M | 4.7M | 1.0 | 0.95 | |
Long Term Debt | 95.0M | 84.0M | 97.1M | 98.3M | 65.7M | 54.2M | |
Retained Earnings Total Equity | (1.3B) | (1.3B) | (1.4B) | (1.4B) | (1.2B) | (1.3B) | |
Short Term Investments | 51.6M | 8.1M | 19.0M | 4.9M | 11.4M | 10.8M | |
Non Current Liabilities Total | 126.6M | 135.9M | 119.4M | 123.0M | 77.7M | 68.1M | |
Capital Surpluse | 1.3B | 1.3B | 1.4B | 1.4B | 1.6B | 952.6M | |
Inventory | 3.2M | 3.5M | 7.1M | 4.5M | 7.1M | 8.2M | |
Other Current Assets | 2.7M | 2.7M | 2.6M | 2.0M | 4.7M | 4.8M | |
Deferred Long Term Liab | 5.8M | 868K | 955K | 743K | 854.5K | 811.7K | |
Property Plant And Equipment Gross | 21.8M | 18.9M | 22.6M | 1.1M | 16.3M | 8.7M | |
Accumulated Other Comprehensive Income | (12K) | 62K | 0.0 | (2K) | (4K) | (4.2K) | |
Intangible Assets | 40.5M | 74.1M | 66.1M | 70.6M | 60.9M | 34.3M | |
Property Plant Equipment | 3.3M | 2.5M | 15.8M | 1.1M | 1.3M | 1.3M | |
Net Receivables | 28.9M | 25.5M | 32.5M | 42.3M | 48.5M | 25.5M | |
Short Long Term Debt Total | 120.2M | 121.0M | 116.6M | 114.3M | 111.5M | 123.2M | |
Long Term Debt Total | 151.9M | 95.0M | 84.0M | 97.1M | 111.7M | 104.8M | |
Net Invested Capital | 112.4M | 92.4M | 94.6M | 119.9M | 153.1M | 135.2M | |
Net Working Capital | 75.5M | 31.9M | 30.4M | 56.8M | 56.8M | 49.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Puma Biotechnology using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Puma Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share 0.32 | Revenue Per Share 4.769 | Quarterly Revenue Growth (0.17) | Return On Assets 0.0919 |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.